scholarly journals iLoF: a blood‐based optical fingerprinting tool for Alzheimer’s disease screening

2021 ◽  
Vol 17 (S5) ◽  
Author(s):  
Mehak Mumtaz ◽  
Simão Faria ◽  
Paulo Santos ◽  
Cristiana Carpinteiro ◽  
Vanessa Pinto ◽  
...  
2021 ◽  
Vol 11 (8) ◽  
pp. 2211-2221
Author(s):  
Yuanbo Xie ◽  
Haitao Jiang ◽  
Hongwei Du ◽  
Jinzhang Xu ◽  
Bensheng Qiu

Alzheimer’s Disease (AD) is a progressive and irreversible neurodegenerative condition, which results in dementia. Mild Cognitive Impairment (MCI) is an intermediate state between normal aging and AD. Instead of traditional questionnaire method, magnetic resonance imaging (MRI) can be used by radiologists to diagnose and screening AD recently, but long acquisition time is not conducive to screening AD and MCI. To solve this problem, we develop a Fasu-Net (Fast Alzheimer’s disease Screening neural network with Undersampled MRI) for AD and MCI clinical classification. The network uses undersampled structural MRI with a shorter acquisition time to improve the screening and diagnosis efficiency of AD. For achieving the best classification result, three axial planes of brain MR images were feed into the Fasu-Net with transfer learning method. The experiment results on undersampled 3D T1-weighted images database (ADNI) show that in the AD versus MCI versus HC (Healthy Controls) classification, the Fasu-Net achieved the accuracy of 91.41%, thus can be a potential method for fast clinical screening of AD.


2012 ◽  
Vol 8 (4S_Part_20) ◽  
pp. S755-S756
Author(s):  
Mitchell Clionsky ◽  
Emily Clionsky

2017 ◽  
Vol 13 (7S_Part_9) ◽  
pp. P482-P482
Author(s):  
Nicole R. Fowler ◽  
Anthony J. Perkins ◽  
Sujuan Gao ◽  
Soo Borson ◽  
Malaz A. Boustani

2013 ◽  
Vol 26 (3) ◽  
pp. 425-434 ◽  
Author(s):  
Sarah R. Braun ◽  
Katinka Reiner ◽  
Christina Tegeler ◽  
Nina Bucholtz ◽  
Malaz A. Boustani ◽  
...  

ABSTRACTBackground:Considering the discussion on implementing routine dementia screening in Germany, the objective of the current study was to validate the German version of the Perceptions Regarding Investigational Screening for Memory in Primary Care (PRISM-PC) questionnaire and to determine the acceptance of Alzheimer's disease screening in elderly German adults.Methods:The German version of the PRISM-PC was administered to a subsample of participants who attended the Berlin Aging Study II (n = 506). The questionnaire was validated by exploratory as well as confirmatory factor analysis.Results:Regarding acceptance of Alzheimer's disease screening (Section B) a single factor structure fitted best. In terms of attitudes regarding Alzheimer's disease (Section D), a hierarchical factor structure was modeled with the higher-order factor “Harms” covering the domains “Family Burden,” “Dependence,” “Emotional Suffering,” “Stigma,” and “Medical Care” on the one hand and the domain “Future Planning” on the other hand. Internal consistency of the different scales reached from α = 0.67 to α = 0.94. Overall, 71.2% of the participants indicated that they wanted to be screened for Alzheimer's disease on a regular basis.Conclusions:This study suggests that acceptance can reliably be assessed with the section “Acceptance of Alzheimer's disease screenings” of the German PRISM-PC questionnaire. Furthermore, the majority of elderly German adults would like to be screened for Alzheimer's disease regularly, which might be an effective starting point in order to implement routine dementia screenings. As the sample is a convenience sample of (relatively) healthy older adults, generalizability of these results is limited.


Sign in / Sign up

Export Citation Format

Share Document